Page 53 - Read Online
P. 53

Pang et al. Mini-invasive Surg 2024;8:27  https://dx.doi.org/10.20517/2574-1225.2023.124  Page 7 of 11

               Robot-assisted resection
               The evolution of head and neck surgery has been markedly influenced by robot-assisted resection, especially
               with the integration of transoral robotic surgery (TORS) for salvage nasopharyngectomies in recurrent NPC
               cases. Robot-assisted nasopharyngectomy is mainly applicable to patients with small recurrent NPC (rT1-
               rT2) that is localized and has minimal invasion into surrounding structures. Ozer et al. blazed the trail in
                                                                                           [46]
               2008 by pioneering transoral robotic nasopharyngectomy as a therapeutic avenue for NPC . This was soon
               followed  by  the  proposition  and  validation  of  combined  transnasal  and  transoral  robotic
               nasopharyngectomy through cadaveric anatomical evaluations [47-49] . Tsang et al. reported that robotic-
               assisted nasopharyngectomy for recurrent NPC achieved a five-year local control rate of 85.1%, an overall
                                                                   [50]
               survival rate of 55.7%, and a disease-free survival rate of 69.1% .
               The distinguishing features of TORS nasopharyngectomy include exceptional tumor visualization provided
               by a 3D camera and the enhanced dexterity of the robotic wrist design, which is especially valuable for
               navigating the tight spaces of the nasopharynx. When the tumor’s extent mandates a sphenoid bone
               resection, a synergistic approach combining transnasal endoscopy and transoral robot assistance proves
               effective [45,51] . Nonetheless, TORS nasopharyngectomy has its limitations, particularly the lack of the tactile
               feedback intrinsic to open surgeries. While TORS can be utilized for retropharyngeal lymph node
               recurrence, its current application remains circumscribed to diminutive recurrent tumors manifesting local
               parapharyngeal invasion.


               Endoscopic microwave coagulation therapy
               In addition to traditional endoscopic approaches, novel techniques such as endoscopic microwave
               coagulation therapy have been explored for managing early recurrent T1 NPC. Mai et al. demonstrated that
               this technique offers a promising alternative for local tumor control with reduced complications and
                                      [52]
               improved patient outcomes .

               Indications for different surgical methods
               Endoscopic nasopharyngectomy
               This approach is particularly suitable for early-stage (T1-T2) or recurrent (rT1-rT2) NPC confined to the
               nasopharynx or parapharyngeal space, with no involvement of critical structures such as the skull base or
               internal carotid artery. It is ideal for patients who cannot undergo radiotherapy or who experience
               significant side effects from prior radiation.

               Robot-assisted nasopharyngectomy
               Recommended for small, localized tumors requiring precise dissection, this method provides enhanced
               visualization and dexterity, making it suitable for early-stage NPC where detailed excision is necessary.

               Maxillary swing approach
               Indicated for cases where early-stage NPC extends into the parapharyngeal space or when greater access is
               required to ensure complete resection. This approach is beneficial when endoscopic methods may not
               achieve clear surgical margins.


               SURVIVAL AND PROGNOSIS
               Surgical treatment of locally recurrent NPC has shown promising outcomes, with 5-year survival rates
               generally ranging from 63% to 77.1%. For nasopharyngeal adenocarcinoma, the 5-year survival rate is
               around 57.1% [16,32,53-56] . Notably, about 30% of patients who receive salvage nasopharyngectomy for recurrent
               NPC eventually succumb to the disease, with distant metastasis being the predominant cause of
   48   49   50   51   52   53   54   55   56   57   58